MedTrace Logo

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

NCT07226804 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-11-10

No results posted yet for this study

Summary

To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.

Conditions

  • Thyroid Nodules
  • Pulsed Field Ablation

Interventions

OTHER

Questionnaire

patient-reported outcomes questionnaire

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Victoria E Banuchi, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-26
Primary Completion
2028-08-31
Completion
2030-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07226804 on ClinicalTrials.gov